Annual report pursuant to Section 13 and 15(d)

License Revenue (Tables)

v3.20.4
License Revenue (Tables)
12 Months Ended
Dec. 31, 2020
Revenue  
Schedule of license revenue

Year Ended December 31, 

2020

2019

Pharmbio Korea Inc.

$

$

Jiangsu Nhwa Pharmaceutical Co. Ltd.

3,000

31

Total license revenues

$

3,000

$

31